glp-1 and bowel obstruction Intolerance Endoscopic Sleeve Options Weighing the Risks: Small Bowel

Use within 2-4 weeks of reconstitution

2010;22(6):664-e203

On TikTok, Reddit, and some telehealth websites, microdosing glucagon-like peptide-1 (GLP-1) receptor agonist medications is pitched as a gentler, more flexible way to use drugs such as the GLP-1 agonist semaglutide (Ozempic, Wegovy), the dual GIP/GLP-1 agonist tirzepatide (Mounjaro, Zepbound), and oral nonpeptide GLP-1 receptor agonist orforglipron (Foundayo)

doi: 10.1038/nm727 68 KillionEAWangJYieJShiSDBatesDMinXet al

The before and after snapshots are real, but the journey between those two photos is where the actual story lives

Shares of several companies tied to the obesity drug boom moved lower following Amazon's Tuesday announcement, including Hims & Hers Health, Viking Therapeutics, Amgen and Septerna.